Baseline Burden of Disease and TDM in Ulcerative Colitis
Study Description
“Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis”
Ulcerative colitis (UC) is a chronic inflammatory bowel disease which often follows a relapsing/remitting course. Anti-TNF therapies are proven to be effective in UC and studies indicate that having adequate drug levels correlate with improved patient outcomes. It is unknown, however, if a high burden of disease at baseline impacts drug utilization or loss. In this study, we investigate whether measures of high burden of disease (fecal calprotectin, bowel ultrasound, and colonoscopy) at baseline predicts low drug levels after standard anti-TNF induction therapy.
Location
Methods
No pharmaceutical medication involved
Recruiting patients only
Diagnostic Test - Fecal calprotectin
Stool test to look at baseline burden of inflammation
Additional Information
Official Study Title
Relationship Between Baseline Burden of Disease and Anti-TNF Drug Trough Levels in Ulcerative Colitis.
Clinical Trial ID
NCT03808506
ParticipAid ID
eXDqle
